KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Free Cash Flow: 2018-2024

Historic Free Cash Flow for Castle Biosciences (CSTL) over the last 7 years, with Dec 2024 value amounting to $36.5 million.

  • Castle Biosciences' Free Cash Flow fell 54.03% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.4 million, marking a year-over-year decrease of 26.52%. This contributed to the annual value of $36.5 million for FY2024, which is 289.85% up from last year.
  • Castle Biosciences' Free Cash Flow amounted to $36.5 million in FY2024, which was up 289.85% from -$19.2 million recorded in FY2023.
  • In the past 5 years, Castle Biosciences' Free Cash Flow ranged from a high of $36.5 million in FY2024 and a low of -$47.3 million during FY2022.
  • Moreover, its 3-year median value for Free Cash Flow was -$19.2 million (2023), whereas its average is -$10.0 million.
  • In the last 5 years, Castle Biosciences' Free Cash Flow slumped by 539.30% in 2021 and then soared by 289.85% in 2024.
  • Yearly analysis of 5 years shows Castle Biosciences' Free Cash Flow stood at $5.1 million in 2020, then plummeted by 539.30% to -$22.5 million in 2021, then tumbled by 110.48% to -$47.3 million in 2022, then surged by 59.30% to -$19.2 million in 2023, then soared by 289.85% to $36.5 million in 2024.